Related Experiment Videos
Subcorneal pustular dermatosis (Sneddon-Wilkinson disease)--therapeutic problems.
The British Journal of Dermatology
|June 1, 1978
Summary
Subcorneal pustular dermatosis can be fatal, with conventional treatments often failing. Systemic retinoic acid derivatives showed promise, offering clinical improvement but not complete remission in a severe case.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Subcorneal pustular dermatosis (SPP) is a rare, chronic inflammatory skin condition.
- SPP can present with severe manifestations and a poor prognosis, posing significant treatment challenges.
Observation:
- A case of subcorneal pustular dermatosis with a fatal outcome is described.
- The patient's condition was refractory to multiple conventional therapies, including corticosteroids, vitamin E, dapsone, sulphapyridine, and levamisole.
Findings:
- Systemic treatment with retinoic acid and a novel aromatic retinoic acid derivative (Ro 10-9359) resulted in a satisfactory clinical response.
- Despite the positive response, a complete remission of the dermatosis was not achieved.
Implications:
- Retinoid therapy represents a potential treatment avenue for severe, refractory subcorneal pustular dermatosis.
- Further research is warranted to optimize retinoid treatment strategies for SPP to achieve complete remission and improve patient outcomes.